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The impact of poly-traumatization on
treatment outcomes in young people with
substance use disorders
Sidsel Karsberg1, Morten Hesse1*, Michael Mulbjerg Pedersen1, Ruby Charak2 and Mads Uffe Pedersen1
Abstract
Background: It is believed that clients with psychological trauma experiences have a poor prognosis with regard
to treatment participation and outcomes for substance use disorders. However, knowledge on the effect of the
number of trauma experiences is scarce.
Methods: Using data from drug use disorder (DUD) treatment in Denmark, we assessed the impact of having
experienced multiple potentially traumatic experiences on DUD treatment efficacy. Baseline and follow-up data
from 775 young participants (mean age = 20.2 years, standard deviation = 2.6) recruited at nine treatment centers
were included in analyses.
Results: Analyses showed that participants who were exposed multiple trauma experiences also reported a
significantly higher intake of cannabis at treatment entry, and a lower well-being score than participants who
reported less types or no types of victimization experiences. During treatment, patients with multiple types of
trauma experiences showed a slower rate of reduction of cannabis than patients with few or no trauma experiences.
The number of trauma types was not associated with number of sessions attended or the development of well-being
in treatment.
Conclusion: Overall, the results show that although traumatized youth in DUD treatment show up for treatment,
helping them to reduce substance use during treatment is uniquely challenging.
Trial registration: ISRCTN88025085, date of registration: 29.08.2016, retrospectively registered.
Keywords: Substance abuse, Treatment outcome, Trauma, Victimization, Cannabis
Background
Trauma experiences refers to serious adverse events that
can instantaneously cause severe distress, and may lead
to the syndrome known as post-traumatic stress disorder
(PTSD). Trauma experiences include life-threatening situ-
ations, such as serious accidents, and also interpersonal
trauma such as serious neglect, sexual abuse, or prolonged
abuse or bullying. General population surveys conducted
in 24 countries indicate that over 70% of individuals report
a traumatic event during their lifetime [1]. However, ex-
perience of a traumatic event does not always lead to
PTSD, but this near ubiquitous exposure can adversely
affect psychological functioning and behavior [2, 3].
Traumatization and poly-traumatization
Recently, researchers and clinicians have increasingly
begun to focus on a particularly high-risk sub-group of
children and youth who has been exposed to several
types of trauma, rather than just a single type of trau-
matic event [4–6]. The theoretical foundation of this
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: mh.crf@psy.au.dk
1Centre for Alcohol and Drug Research, Aarhus University, Bartholins Allé 10,
8000 Aarhus, Denmark
Full list of author information is available at the end of the article
Karsberg et al. BMC Psychiatry          (2021) 21:140 
https://doi.org/10.1186/s12888-021-03129-x
new focus is the cumulative risk theory which states that
the higher the number of risk factors a person is exposed
to, the higher the potential for a negative outcome [7] and
the underlying dose response model which illustrate that
the accumulation of traumatic events is often a stronger
predictor of outcomes than single event exposure [8].
Individuals with a history of poly-traumatization have
been shown to continue to experience additional
victimization [9], severe and persistent biopsychosocial
impairment [10, 11], and are at increased risk of devel-
oping negative behavioral patterns such as delinquency
and substance abuse compared to individuals with few
or no trauma experiences [12, 13]. In a study of youth
involved in the juvenile justice system, investigators con-
ducted a latent class analysis derived from 19 types of
adversity, including different forms of violence exposure
produced three unique classes. Among the three classes
that emerged, the poly-trauma group was distinct from
other adversity groups in the presence of severe emo-
tional and behavioral problems [14]. In another recent
longitudinal study that included 1186 adolescents, poly-
victimization was linked to lower levels of social support,
self-esteem, and mastery [15]. However, in recent studies
that examine the accumulative effect of trauma
victimization, certain specific types of traumatic expo-
sures, for instance, child sexual abuse have also been
shown to account for impairment over and above the
cumulative impact of the number of specific exposure
types [16–18]. None-the-less, the established links be-
tween multiple types of trauma, negative behavioral pat-
terns, and cognitive functions may carry important
implications for substance abuse treatment, particularly
in relation to treatment efficacy.
Traumatization and substance use treatment
The link between trauma experiences and substance use
disorders (SUD) is well established [4]. In surveys of ad-
olescents receiving treatment for substance abuse, be-
tween 60% and 87% of patients reported a history of
exposure to trauma [5, 6]. Moreover, studies show that
37% to 52% of SUD patients have a lifetime diagnosis of
PTSD [7, 8]. In particular, the literature has focused on
experiences of childhood abuse as an underlying risk
factor for substance use behaviors [9–11]. Examining
the effect of trauma history on SUD treatment out-
comes is important, because the treatment of SUD pa-
tients with a trauma history may need to be adjusted to
the needs of the patient based on their trauma experi-
ences [19, 20]. For instance, treatment may lead to ex-
posure to cues related to the traumatic events. This
may, if unaddressed, produce symptoms of anxiety or
anger, in turn leading to patient attrition, or reinitiating
substance use to cope with intruding memories and
avoidance symptoms [21, 22].
However, overall, the influence of previous trauma ex-
periences on the effect of SUD treatment is unclear. A
number of studies have indeed indicated that individuals
with past trauma experiences, have poorer outcomes of
substance abuse treatment including worse treatment
adherence and less improvement during treatment [23–
27]. Yet, other studies have found that past trauma expe-
riences are not a predictor of poor prognosis or missing
appointments in SUD treatment [28–30].
The majority of studies that have examined associa-
tions between specific trauma experiences and substance
use disorder (SUD) treatment outcomes, have focused
on single types of childhood trauma such as physical or
sexual abuse [30–33]. Childhood trauma as an overall
category has been found to be a predictor for earlier
drop-out from SUD treatment [34], higher rates of re-
lapse [35] and less improvement in treatment measured
by drug use and psychological functioning [36]. Also,
Parolin and colleagues found that young drug users re-
ceiving drug use disorder (DUD) treatment who had
been exposed to parental substance abuse during their
developmental age, had elevated rates of neuropsycho-
logical impairments, particularly affecting the attentive
and executive functions, compared to drug users who
were not exposed to parental substance abuse [37].
However, to our knowledge, existing studies have not
controlled for the effect of other trauma exposure on
treatment outcomes and therefore it is unclear whether
it is indeed the specific type of trauma or an accumula-
tive effect of trauma exposure that is associated with
treatment effect.
In light of the inconsistent findings, there is a need for
additional research that examines the role of past trauma
experiences in substance abuse treatment settings. In
particular, very few studies have examined the influence
of the number of trauma experiences in relation to out-
comes of DUD treatment. To strengthen knowledge in
the substance abuse treatment field, this study aimed to
examine the effect of poly-traumatization on treatment
effect in a Danish treatment for DUD based on
cognitive-behavioral therapy.
Since the word trauma holds multiple meanings, it is
important to point out that the events referred to as
trauma in the present study are only potentially trau-
matic, meaning that they may or may not have caused
trauma symptoms. The same applies for the term poly-
traumatization, which in this study covers multiple types
of trauma experiences and not the level of trauma symp-
tomatology. Recent trauma studies have used the terms
correspondingly [38, 39].
Study aims
Based on the cumulative risk theory and existing studies
that link accumulative trauma to a lower SUD treatment
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effect, as well as various negative psychosocial and be-
havioral factors that are relevant for treatment outcome,
such as self-esteem, social support and mastery [15], at-
tentive and executive functions [30], and severe emo-
tional and behavioral problems [5, 12], the overall
research question for the present paper was whether
participants with trauma exposure, and in particular a
high number of traumatic experiences, would be less
likely to benefit from DUD treatment than participants
with no or few trauma experiences. This focus led to the
following three hypotheses:
1) Trauma history would be associated with a slower
reduction in cannabis use during treatment in an
approximately dose-dependent fashion, in that the
fastest decline in cannabis use would be seen among
participants with no traumatic history, and the
slowest among those with poly-traumatization.
2) Trauma history would be associated with a slower
improvement in well-being during treatment in a
similar dose-dependent fashion.
3) Treatment attendance would be associated with
trauma history, in that patients with zero trauma
experiences would attend the most sessions, followed
by patients with few types of trauma, and that the
patients with the highest number of trauma
experiences would attend the fewest sessions.
Since similar studies have shown that factors such as
gender [40, 41], socio economic status [42], immigrant
status/ethnic minority status [43], and age [44, 45] may
play a great role in relation to SUD treatment outcome,




The study combined data from two sources: one was a
randomized controlled clinical trial [46] that examined
the effect of a motivational enhancement and CBT-
based intervention. Participants were recruited by staff
at nine participating treatment centers. The second
source was data collected from the same nine sites dur-
ing the post-trial phase of the clinical trial, when treat-
ment components were implemented in day-to-day
practice1.
All participating sites offered outpatient treatment for
youth with illicit DUDs in agreement with the Danish
Consolidation Act on Social Services under Part 18, §
101. According to the act, treatment must be offered
without co-payment, and within two weeks after clients
have contacted the treatment services.
Participants were eligible if they were between the ages
of 15 and 25 years, and had contacted the treatment cen-
ter with the intention of entering treatment for DUD.
Clients were excluded if they sought treatment for an
opioid use disorder, had known active psychotic disor-
ders, known cognitive deficits, and/or were otherwise
deemed not safe to participate (e.g., had recently en-
gaged in violent actions against staff). The reason for ex-
cluding participants with opoid use disorders was that
treatment for this particular group is often focused on
substitution medicine and this focus is very important
throughout treatment. It was therefore assessed that the
offered treatment would cover this essential focus for
this particular group well enough. The demographic
characteristics are summarized in Table 1.
Procedures
Eligible clients were invited to take part in the clinical
trial by clinical staff at each of the nine treatment
centers.
From September 2014 to May 2016, clients were in-
vited to participate in the clinical trial, and from the end
of May 2016 and until October 2017, all eligible clients
were asked if they would consent to the use of their
1Trial registration: ISRCTN27473213, https://doi.org/10.1186/
ISRCTN27473213
Table 1 Baseline characteristics total sample
n = 775
Female gender 22.7% (n = 176)
Mean age 20.3 (2.65)
Immigrant 9.9% (n = 77)
Not in education, employment or training 36.5% (n = 283)
Days of cannabis use within last month 17.6 (11,34)
Binge drinking/typical week 0.82 (1.20)
Days of cocaine use within last month 1.15 (3.2)
Days of ecstasy/MDMA use within last month 0.42 (1.9)
Days of illegal behavior for profit within last month 2.44 (6.37)
Self-reported psychiatric diagnosis 34.7% (269)
Bullying 41.3% (n = 302)
Neglect 58.7% (n = 451)
Sexual assault 15.9% (n = 124)
Physical assault 52.1% (n = 414)
Threats 63.3% (n = 482)
Accident 31.5% (n = 243)
Severe disease 33.4% (n = 259)
Death of parent or sibling 14.7% (n = 104)
0 potentially traumatic events 8.3% (n = 64)
1–4 potentially traumatic events 69.7% (n = 540)
5–8 potentially traumatic events 22.1% (n = 171)
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assessment data for research purposes and quality
assurance.
Interventions
All participating clients were offered 12 sessions of
manual-based counselling incorporating a combination
of cognitive behavioral therapy and motivational inter-
viewing (see Table 2).
In addition to this manual based counselling (standard
treatment), some participants received vouchers for at-
tendance, reminders of sessions, or both vouchers and
reminders [46]. Based on the variety of treatment com-
ponents, the potential effect of different treatment tracks
was controlled for in our analyses (i.e., the four random-
ized groups and the post-trial phase).
Measures
At the first counselling session after trial participation,
all clients were assessed using the YouthMap assessment
form [47]. The YouthMap assessment form is a compre-
hensive assessment tool, tailored for young people in
treatment for psychoactive substance use disorders. The
YouthMap covers background information, current sub-
stance use, past and current behavioral and mental prob-
lems, victimization experiences, peer and family
relations amongst others. Additionally, during the treat-
ment course all participants were assessed in each ses-
sion with the TEM screening tool [48, 49]. TEM is a
routine outcome monitoring tool that consists of eight
questions based on the feedback informed treatment ap-
proach [50, 51]; five questions related to drug use and
three questions related to well-being. All responses were
entered into a secure web-based interface at baseline by
the involved researchers.
Lifetime exposure to traumatic events
To measure the type and number of past trauma experi-
ences the following eight items from the YouthMap sur-
vey were selected: 1) Have you ever been the victim of
bullying?”, 2) “Have you ever been the victim of neg-
lect?”, 3) “Have you ever been the victim of a sexual as-
sault?”, 4) “Have you ever been the victim of a physical
assault?”, 5) “Have you ever received threats to your
health or life?”, 6) “Have you ever been involved in a ser-
ious accident, such as a traffic accident or a work-related
accident?”, 7) “Have you ever experienced that you, your
parents, or your siblings were seriously ill.”, 8) “Have
you ever experienced the death of a sibling or parent?”
For bullying, the responses were rated on a five-point
Likert scale from 1 (“Not at all”) to 5 (“extensively”), and
all other trauma victimization items were dichotomized
(yes/no).
Moreover, clinicians registered all completed counsel-
ling sessions and all non-attendances for their clients.
Outcomes
Three central outcomes of interest were considered for
this study: 1) cannabis use during treatment, 2) psycho-
logical well-being during treatment, and 3) session at-
tendance. Due to the small proportion of participants
who used other types of drugs but not cannabis, we only
included participants who reported cannabis use in the
analyses of effects on drug intake.
Cannabis use during treatment was measured by ask-
ing about the number of times per day within the last
week that the participant had smoked cannabis. Canna-
bis use was recoded into number of days with any can-
nabis use. Well-being was measured by a composite
score using three questions: 1) “How well have you gen-
erally been feeling during the seven days?”, 2) “How well
have you generally felt about your close relationships,
e.g., family or close friends, during the past seven days?”,
and 3) “How well have you generally felt socially, e.g. at
work or school, during the past seven days?”. The three
items are from the outcome rating scale (ORS) which
consists of four items [52]. Previous studies have found
that the ORS has high test-retest reliability, strong in-
ternal consistency, and moderate to good concurrent
validity [52–54].
All three items were measured on a 10-point scale ran-
ging from 0) “very bad” to 10) “very good”. To measure
attendance each session up to session 12 was dummy-
coded as attended or missed. Thus, it was possible for
participants to have a pattern of attendance consisting of
a mix of sessions attended (e.g., two attended, one
missed, followed by nine attended).
Control variables
For the three regression variables, random intercepts
were estimated for site and client. In addition, the ana-
lyses were controlled for gender, age (measured as an
interval scale), not being in education, employment or





n = 114 n = 113 n = 112 n = 121 n = 315
12 sessions standard
treatment (MI/CBT)





12 sessions standard treatment
(MI/CBT) + vouchers + reminders
12 sessions standard treatment
(MI/CBT) + reminders + vouchers
(optional)
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training (single, dummy coded variable), and migration
status (dummy coded as having at least one Danish par-
ent versus all others).
Analytic plan
To assess poly-traumatization, the sample was divided
into three trauma categories based on the number of re-
ported trauma experiences. The trauma types do not
represent a scale, as each is a potentially independent
event from the others, rather than different manifesta-
tions of the same underlying construct. For this reason,
we chose to analyze the number of different traumatic
events as an index [55]. That is, a measure of factors that
may all individually contribute to the same phenomenon
(in this case, being burdened by the impact of traumatic
events). We used the eight items measuring trauma
victimization. For seven of the eight trauma variables the
response “yes” was coded as trauma victimization. For
bullying, answers were only coded as trauma
victimization if participants had responded “to some ex-
tent”, “a lot”, or “extensively”. Individuals were grouped
as zero trauma experiences, one to four trauma experi-
ences, or five or more trauma experiences.
A mixed effects Tobit regression was conducted for
days of cannabis use. Days of cannabis use was censored
at zero days (i.e., past week abstinence) and 7 days (i.e.,
daily use). The variables of interest were status in terms
of trauma exposure measured on a nominal scale (i.e.,
zero trauma types, one to four trauma types, or five or
more trauma types), and the interaction between trauma
status and session. The interaction between trauma and
session was included in order to assess the slope of days
of cannabis use as a function of trauma categories (i.e.
the number of different types of victimization).
A mixed effects logistic regression was conducted for
session attendance. The variables of interest were again
status in terms of trauma measured on a nominal scale
(i.e., zero trauma types, one to four trauma types, or five
or more trauma types), and the interaction between
trauma status and session.
A linear mixed effects regression was conducted for
well-being. The variables of interest were again status in
terms of trauma measured on a nominal scale (i.e., zero
trauma types, one to four trauma types, or five or more
trauma types), and the interaction between trauma sta-
tus and session.
Finally, two graphs were produced to illustrate the
course of cannabis use and well-being throughout treat-
ment. For use of cannabis and well-being, a fractional
polynomial fit was used to assess days of cannabis use as
a function of session, stratified by degree of poly-
traumatization.
Missing data can influence the results of a prospective
clinical study, when data is not missing completely at
random. While there is no one solution to this issue,
one way to reduce the influence of missing data is to
conduct sensitivity analyses adjusting for factors that are
likely to influence missingness [56]. While we cannot
guarantee that we can identify all factors that are associ-
ated with missing data, we do know that randomization
to any of the active treatment groups in our study in-
creased attendance and reduced no-shows [57].
As a sensitivity analyses, all analyses were conducted
controlling for treatment group (four randomized groups
and post-trial status). Further sensitivity analyses were
conducted controlling for the externalizing and internal-
izing scales of the YouthMap measure [58].
Results
Participants
A total of 775 participants were included in the study, of
which 599 were male and 176 were female. The mean
age was 20.2 years (standard deviation [SD] = 2.6, range =
15 to 25). At baseline, the participants reported smoking
cannabis on average 17.6 days in the past 30 (SD = 11.3,
range 0 to 30) and 4.04 days in the past 7 days (SD =
2.77, range 0–7). A total of 38% reported use of drugs or
substances other than cannabis or alcohol.
Poly-traumatization
Of the participants, 64 (8.3%) had never experienced any
of the eight trauma experiences, 540 (69.7%) had experi-
enced between one and four of the events, and 171
(22.1%) had experienced five or more of the eight events.
The incidence of each trauma type across groups is
shown in Table 3.
Cannabis use during treatment
Figure 1 shows days of cannabis use in the last week as a
function of time.
The mean number of days declined from 4.04 on aver-
age at baseline (SD = 2.77) to 2.16 days at the twelfth ses-
sion for the participants who completed all sessions (n =
134, SD = 2.88). The results of the Mixed Effects Tobit
regression are shown in Table 4. The model Wald χ2 test
was significant (χ2(13) = 268.1, p < 0.001).
In the unadjusted analyses, few or multiple trauma ex-
periences were associated with a higher degree of canna-
bis use compared with no trauma history (one to four
versus zero: p = 0.045; five or more versus zero: 0.010).
With each session, days of cannabis declined (p < 0.001).
The decline was less for those with a trauma history
(one to four versus zero: p = 0.033; five or more versus
zero: p = 0.004).
After controlling for confounders, clients who reported
one to four types of trauma no longer differed signifi-
cantly at baseline (coefficient = 1.65, CI − 0.09–3.22, p =
0.064), but clients who reported five or more types of
Karsberg et al. BMC Psychiatry          (2021) 21:140 Page 5 of 14
trauma continued to show significantly more cannabis
use at baseline (coefficient = 2.06, CI 0.20–3.91, p =
0.030). In terms of reductions in cannabis use over time,
both clients who reported one to four of the trauma (co-
efficient = 0.19, CI = 0.04–0.33, p = 0.010), and clients
who reported five or more of the trauma types (coeffi-
cient = 0.25, CI = 0.09–0.40, p = 0.002), showed a slower
rate of decline in days of cannabis use compared to cli-
ents who did not report any of the trauma types, as indi-
cated by significant group by time interactions.
The sensitivity analyses were not meaningfully differ-
ent from the original analysis. As in the original analysis,
both groups that reported trauma were less likely to re-
duce their cannabis use during treatment compared with
those who did not report any of the trauma types.
Session attendance
Clients with zero trauma types attended on average 6.5
sessions (SD = 4.7), clients with one to four trauma types
attended on average 6.5 sessions (SD = 4.3), and clients
with five or more trauma types attended on average 7.0
sessions (4.3). Table 5 shows the results of random ef-
fects logistic regression to predict session attendance.
Compared with clients with zero trauma types, those
with one to four (p = 0.036), and those with five to eight
types (p = 0.038) were more likely to attend treatment at
later sessions as indicated by significant session by group
interactions.
The marginal probability of attending sessions over
time as a function of trauma victimization is shown in
Fig. 2.
Table 3 Incidence of trauma by level of victimization
Zero (n = 64) One to four (n = 540) Five or more (n = 171)
Bullying – 31.5% 77.2%
Neglect – 54.3% 92.4%
Sexual assault – 9.6% 42.1%
Physical assault – 47.0% 93.6%
Threats of violence – 60.4% 91.2%
Accidents – 27.2% 56.1%
Disease – 26.5% 67.8%
Death of family member – 10.6% 27.5%
Fig. 1 Days of cannabis use as a function of session by degree of poly-traumatization
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Well-being
A reliability analysis was carried out on the 3-item
wellbeing scale. Cronbach’s alpha showed the scale to
reach acceptable reliability, α = 0.71.The results of the
logistic regression analysis for the association between
well-being and the number of trauma types are shown
in Table 6 and Fig. 3. In both the unadjusted (the
second column of Table 6) and the adjusted models
(column 4), trauma history was associated with lower
overall well-being, but time by trauma interactions
were non-significant, indicating that the rate of
change did not differ between more or less trauma
types. In all cases, well-being improved substantially
over time in treatment.
Table 4 Predictors of days of cannabis use (Tobit regression, n = 775)
Coefficient P-value 95% CI Coefficient P-value 95% CI
Trauma
Zero trauma types Reference – – Reference – –
1–4 trauma types 1.85 0.029 0.19; 3.51 1.56 0.064 -0.09; 3.22
5–8 trauma types 2.71 0.004 0.87; 3.54 2.06 0.030 0.20; 3.91
Session −0.58 0.000 −0.72; −0.44 − 0.58 0.000 −0.71;-0.44
Trauma*session
1–4 trauma types 0.29 0.010 0.05; 0.33 0.19 0.010 0.04; 0.33
5–8 trauma types 0.001 0.10; 0.40 0.25 0.002 0.09; 0.40
Female gender (reference: male gender) – – – 1.13 0.033 0.09; 2.17
Age 0.12 0.158 −0.05; 0.29
Not in education, employment or training
(reference: working or studying)
1.32 0.005 0.40; 2.24
Immigrant (reference: Danish) 0.17 0.810 −1.25; 1.60
Constant 2.05 0.441 −3.16; 7.26
Intraclass correlation:
Site < 0.01 – –
Client 0.72 – 0.69; 0.75
Table 5 Predictors of session attendance (n = 775)
Odds ratio 95% CI P-value Adjusted Odds Ratio 95% CI P-value
Trauma Reference – – Reference – –
Zero trauma types 0.38 0.12; 1.17 0.092 0.36 0.12–1.07 0.067
1–4 trauma types 0.56 0.16; 1.91 0.353 0.54 0.16–1.83 0.320
5–8 trauma types 0.53 0.48; 0.58 0.000 0.52 0.47–0.58 0.000
Trauma*session
1–4 trauma types 1.11 1.00; 1.23 0.050 1.12 1.01–1.24 0.036
5–8 trauma types 1.12 1.00; 1.25 0.055 1.13 1.01–1.26 0.038
Female gender (reference: male gender) – – – 1.82 1.03–3.19 0.038
Age 1.18 1.07–1.29 0.001
Not in education, employment or training
(reference: working or studying)
0.31 0.19–0.50 0.954
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Sensitivity analyses
None of the sensitivity analyses yielded markedly differ-
ent results.
Discussion
On the basis of existing knowledge [59, 60], it is not sur-
prising that the vast majority (91.8%) of the 775
participants in DUD treatment, had experienced one or
more of the eight trauma types examined in this study,
and that one out of five (22.1%) had experienced five to
eight of the trauma types. However, considering the young
age of the participants, the prevalence is indeed alarming
and does strongly underline the importance of being very
attentive to previous victimization in DUD treatment.
Fig. 2 Marginal probability of attending sessions as a function of time and poly-traumatization
Table 6 Predictors of self-reported wellbeing (n = 775)
Coefficient 95% CI P-value Adjusted Coefficient 95% CI P-value
Trauma
Zero trauma types Reference – – Reference – –
1–4 trauma types −0.73 −1.19–-.27 0.002 −0.62 −1.07– 0.17 0.007
5–8 trauma types −1.20 −1.70–-0.70 0.000 −0.92 1.42–0.42 0.000
Session 0.09 0.05–0.13 0.000 0.09 0.05–0.13 0.000
Trauma*session
1–4 trauma types −0.00 −0.05–-0.04 0.891 −0.00 − 0.05–0.04 0.890
5–8 trauma types −0.03 − 0.08–0.01 0.159 − 0.03 − 0.08–0.01 0.161
Female gender (reference: male gender) −0.74 −1.00–-0.48 0.000
Age −0.05 − 0.09–-0.01 0.022
Not in education, employment or training
(reference: working or studying)
−0.21 −0.45–0.02 0.070
Immigrant (reference: Danish) 0.03 −0.32–0.28 0.860
Constant 7.08 6.65–7.51 0.000 8.96 7.94–9.97 0.000
Intraclass correlation:
Site < 0.01
Client 0.53 0.49–0.56 0.51 0.48–0.55
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In this study, we found support for hypothesis-1 in
that individuals who reported exposure to multiple types
of trauma were less likely to reduce their use of cannabis
in treatment and at a slower rate than individuals who
reported fewer types or no types of trauma. In addition
to this finding, our analyses also indicated that poly-
traumatized youth enter DUD treatment with a higher
use of cannabis than individuals with less types of
trauma experiences.
Substance use severity at treatment entry has been
negatively associated with treatment efficacy as indi-
cated by higher substance use at follow-up [61],
higher drop-out rate [62], relapse [63], and suicide at-
tempt one year after treatment [64]. Similar to the
present study, prior studies have also found a history
of trauma victimization to be positively associated
with severity of current substance use [65–67]. A
higher consumption of cannabis at treatment entry, in
itself, seems to provide a challenge for treatment of
this specific group.
It is important to note that the associations between
cannabis intake and number of trauma types were
established without considering the psychological im-
pact of the trauma experiences. If we had performed
our analyses solely on a sample who reported being
psychologically affected by their experiences, the asso-
ciation with cannabis may have been much stronger.
A major hypothesis for the relationship between
victimization and problematic substance use is that
substance use is a coping strategy for dealing with
the physical or emotional discomfort associated with
the trauma of victimization. This includes using sub-
stances to avoid, escape or distract from the over-
whelming distress associated with trauma-related
memories [68, 69]. Although we did not measure
traumatization or trauma symptoms in the present
study, it is indeed possible that trauma symptoms are
a causal factor behind the found association with a
higher intake of cannabis and slower reduction of
cannabis use in the poly-traumatized group. The
probability of developing trauma related symptoms [4]
and PTSD [12] increases with the number of
victimization experiences and thus it is indeed likely
that the rate of PTSD is higher in the poly-trauma
group. In prior studies, PTSD symptoms have been
shown to be associated with a higher cannabis intake
and reduction of intake in treatment [65]. However,
this association is very complex and the relationship
between victimization and substance use has been
shown, for instance, to vary across types of
victimization experiences due to differences in emo-
tional regulation [70]. Thus, the trajectories from
victimization to substance use are many, and expos-
ure to multiple traumatic events is one aspect in this
complex interplay.
Due to the close relationship between trauma and
substance-use, an increasing number of researchers and
practitioners argue that the close relationship shared be-
tween trauma and substance misuse should be fully inte-
grated into SUD treatment programs and that
Fig. 3 Self-reported well-being as a function of session by degree of poly-traumatization
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“Wherever possible, emphasis should be placed on the
deep-rooted connection between trauma, mental health,
and addiction” [71]. Although still not widely imple-
mented, trauma focused interventions such as e.g. seek-
ing safety [20, 25] has shown promising results,
indicating that traumatized individuals in DUD treat-
ment do benefit from a more integrative approach.
In order to target treatment at trauma-related issues,
the first step is identification of such issues. Identifying
individuals at particular risk in treatment is an important
tool in treatment planning. It is possible that the level of
traumatization may be a more precise risk indicator for
treatment outcome than the number of trauma experi-
ences in DUD treatment. However, we also need to re-
late to the current reality in DUD treatment settings.
Although trauma symptoms and PTSD is far more
prevalent in substance treatment settings than in the
general population [72, 73] a very large proportion of
clients with trauma symptoms remain unidentified and
undiagnosed throughout treatment [72, 73]. In
Denmark we do not routinely screen for PTSD in DUD
treatment, and, to our knowledge, this is still not stand-
ard practice in most treatment centers around the
world. It goes without saying that when clinicians in
treatment facilities have no knowledge about clients´
trauma symptomatology, they cannot use it in treat-
ment planning or risk assessments. However, in the
majority of treatment facilities in Denmark we do
screen for previous victimization experiences in DUD
treatment. The present finding of the association be-
tween poly-traumatization and higher intake of canna-
bis at treatment entry and slower reduction throughout
the treatment course may thus provide practitioners
who holds knowledge about the victimization history of
their clients but no knowledge on the degree of
traumatization, indication of potential challenges in
their treatment course.
In addition to specific factors associated with
victimization, it is possible that slow progression in re-
duction of cannabis use in the poly-traumatized group
could create a negative motivational spiral. It is well-
known that the perception of making progress is import-
ant for personal motivation in any type of life change
[74]. Clients and therapists often report lack of motiv-
ation as the main cause of non-successful treatment
[75]. If poly-traumatized youth are experiencing less pro-
gress in terms of being able to reduce their intake of
cannabis, their motivation for change in treatment may
be affected negatively. Indeed, one study that examined
motivational factors in treatment found that individuals
who experienced slow or no progression towards their
treatment goals more often had a perception of low
competence which in turn led to less motivation for
treatment [76]. In treatment, lack of motivation often
leads to drop-out [77]. However, we did not find support
for a higher drop-out rate among the poly-traumatized
youth in the present study. It is, however, still possible
that due to less progress in reduction of cannabis intake,
motivational factors such as the perception of low
competence may have negatively influenced this group’s
ability to reduce their cannabis intake. Changes in mo-
tivation due to lack of progress could therefore be an
important focus for traumatized patients in DUD treat-
ment. Since, we did not measure any motivational fac-
tors, this hypothesis, however, remains unanswered in
the present study.
In contrast to our hypothesis-3, number of sessions
attended was positively associated with reported number
of trauma types. In contrast, the groups that reported
multiple trauma experiences (i.e. one to four and five to
eight) were more likely to attend treatment sessions than
the group of clients with no trauma experiences. This is
indeed an encouraging finding, especially considering
that several large-scale substance abuse treatment out-
come studies have underscored the importance of length
of time or retention in treatment as the most stable pre-
dictor of positive outcome [78, 79]. This finding is in
fact consistent with the very modest associations be-
tween PTSD and retention in treatment for SUD pre-
sented in a recent narrative review. This review
concluded that there is no clear pattern showing that pa-
tients with co-occurring PTSD are more likely to drop
out from treatment than other patients with SUD [80].
However studies that have found associations between
traumatization and retention in SUD treatment still sug-
gest that there are important variables which modify the
effect of trauma experiences on SUD treatment effect. In
the above review, Hildebrand and colleagues suggest to
further examine age, duration of treatment, types of sub-
stance use, length of follow-up, and method of assess-
ment as potential explanatory factors for the differing
results [80]. Also, we believe that more research into dif-
ferences between specific victimization experiences, the
victims´ perception of the experience and trauma symp-
toms would offer interesting insight in this context. For
instance, it is likely that a large proportion of partici-
pants did not perceive their experiences as traumatic or
have experienced persistent trauma symptoms [81]. A
mixed method approach that also includes qualitative
in-depth explorations of the reported trauma experi-
ences, experienced trauma symptoms and experienced
treatment outcomes would offer more detailed insight in
differences between participants reporting many trauma
experiences and trauma symptoms with the group
reporting many trauma experiences and no or few
trauma symptoms in relation to treatment attendance.
Also, our hypothesis-2 that the groups with a trauma
history would experience less progress in wellbeing in
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DUD treatment compared to the group with no trauma
history, was not supported either. The reported level of
wellbeing at treatment entry (baseline) was, however,
significantly lower in both the group with one to four
types of trauma experiences as well as the group with
five to eight types of trauma experiences, with the lowest
score in the latter group. This finding indicates, that al-
though the two groups had similar positive progression
in symptoms throughout treatment, overall they had a
lower well-being score, which in turn, combined with
their higher intake of cannabis, suggests that they were
more vulnerable throughout the treatment, as well as
post treatment, compared to the group that reported no
trauma experiences.
Limitations
Firstly, self-reports of victimization experiences and sub-
stance use have their limitations. Specifically, questions
on victimization that are not behavior-specific have been
criticized because they may underestimate incidents
since these questions assume a respondent will
categorize their experience as abuse or be willing to self-
identify as a victim [82]. It is argued, that people who
have experienced physical or sexual abuse may not
recognize that what they experienced was against the
law or may be reluctant to categorize what they experi-
enced as abuse [83]. However, this argument may be
more relevant in surveys that examines the general
population than in DUD treatment. Individuals in DUD
treatment may be more prone to report victimization ex-
periences, firstly because they are already in a develop-
mental process in which they have recognized that they
have a serious problem, and secondly, because that in-
formation could help their counsellor plan their treat-
ment course. Due to the very high prevalence of
victimization experiences in the present study, underre-
porting of victimization experiences do not seem to be
an issue, but indeed more detailed and behavior-specific
measures are recommended. Further, the validity of re-
ported drug use has been questioned in multiple studies
[84] and the measure we used for substance use has not
been validated in a Danish context. It is indeed possible
that both recall bias and underreporting may have influ-
enced thhe drug use reports. However, we only asked for
drug use within the past 7 days, which has minimized
the influence of a recall bias. Even so, further research
into the validity of the particular measure used in the
present study is warranted. It is furthermore a limitation
that we only measure the treatment effect on drug use
via cannabis use. However, due to the low frequency of
use of other drugs, it was not statistically meaningful to
include these in this study. It is indeed possible that the
interaction between traumatic experiences and treat-
ment effect varies considerably depending on drug type
or the presence of multiple drug use versus single drug
use. More research into these variations is recom-
mended. Also, we did not have data to examine the se-
verity of trauma experiences and to which degree the
participants were affected by their experiences. Conse-
quently, we do not know if the level of traumatization is
a causal factor and perhaps even the most important fac-
tor in the relationship between the number of trauma
experiences and treatment outcome. Finally, an import-
ant limitation is that the findings do not generalize to
participants who dropped out of treatment or cancelled
multiple sessions. Thus, the results should be interpreted
as representing the influence of trauma on progress dur-
ing treatment, not beyond it.
Conclusion
Overall, the results in this study support the hypothesis
that poly-traumatized youth in DUD treatment may be
harder to treat, due to a higher intake at treatment entry
and a slower decline throughout treatment. In con-
trast to our hypotheses, analyses showed that the
number of sessions attended and the progression in
wellbeing in treatment were not affected by the num-
ber of trauma experiences. Since attendance has been
found to be one of the most stable indicators for
DUD treatment success, the non-significant associ-
ation between trauma history and attendance is par-
ticularly an encouraging finding. However, specific
psychological symptoms, social circumstances, and
negative behaviors related to trauma, still emphasize
the need for a specialized approach for victimized cli-
ents in DUD treatment.
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